{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:41:39Z","timestamp":1761237699559},"reference-count":34,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2010,3,15]],"date-time":"2010-03-15T00:00:00Z","timestamp":1268611200000},"content-version":"vor","delay-in-days":14,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Internal Medicine Journal"],"published-print":{"date-parts":[[2010,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Direct\u2010to\u2010consumer personal genome testing (DTC\u2010PGT) screens a customer's genome for the presence of single nucleotide polymorphisms that are reported to be associated with various diseases, disease risk factors and personal characteristics. The range of health risks covered by personal genome testing (PGT) includes cancer, heart disease, obesity, diabetes mellitus and osteoporosis. PGT also detects a range of other characteristics, such as alcohol \u2018flush reaction\u2019, eye colour, ear wax type and bitter taste perception. Information about ancestry and family history is also available. Although DTC\u2010PGT is still a relatively new enterprise, the technology has the potential for rapid expansion as it becomes more accessible to consumers who wish to obtain information about their genetic profile. This review provides an overview of the broader ethical and regulatory issues raised by personal genome tests that are marketed directly to the public, and that purport to provide information about health risks. We discuss the emergence of DTC\u2010PGT in Australia, and the possible regulatory responses that may be taken to manage it.<\/jats:p>","DOI":"10.1111\/j.1445-5994.2010.02190.x","type":"journal-article","created":{"date-parts":[[2010,3,15]],"date-time":"2010-03-15T04:42:01Z","timestamp":1268628121000},"page":"220-224","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Direct\u2010to\u2010consumer personal genome testing: ethical and regulatory issues that arise from wanting to \u2018know\u2019 your DNA"],"prefix":"10.1111","volume":"40","author":[{"given":"G. N.","family":"Samuel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. F. C.","family":"Jordens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Kerridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,3,15]]},"reference":[{"key":"e_1_2_6_2_2","unstructured":"Genetic Health Personal Health Management [Homepage on the Internet]. [cited 2009 Aug 10]. Available from URL:http:\/\/www.genetic\u2010health.co.uk\/dna\u2010test\u2010services\/obesity\u2010test.htm"},{"key":"e_1_2_6_3_2","unstructured":"Eastern Biotech and Life Sciences [Homepage on the Internet]. [cited 2009 Aug 10]. Available from URL:http:\/\/www.easternbiotech.com\/test_centers.php"},{"key":"#cr-split#-e_1_2_6_4_2.1","unstructured":"CBC News.Personal DNA Testing Comes to Canada. [updated 2008 Jan 23"},{"key":"#cr-split#-e_1_2_6_4_2.2","unstructured":"cited 2009 Aug 10]. Available from URL:http:\/\/www.cbc.ca\/health\/story\/2008\/01\/23\/dna\u2010sale.html"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11673-007-9062-5"},{"key":"e_1_2_6_6_2","unstructured":"deCODEme [Homepage on the Internet]. [cited 2009 Aug 10]. Available from URL:http:\/\/www.decodeme.com\/complete\u2010genetic\u2010scan"},{"key":"e_1_2_6_7_2","unstructured":"National Cancer Institute [Homepage on the Internet]. National Cancer Institute Fact Sheet. [cited 2009 Aug 10]. Available from URL:http:\/\/www.cancer.gov\/cancertopics\/factsheet\/risk\/brca"},{"key":"e_1_2_6_8_2","unstructured":"Health Insite: An Australian Government Initiative [Homepage on the Internet]. Huntington's Disease. [cited 2009 Aug 10]. Available from URL:http:\/\/www.healthinsite.gov.au\/topics\/Huntington_s_Disease"},{"key":"e_1_2_6_9_2","unstructured":"FlemingN.Rival genetic tests leave buyers confused.The Sunday Times. 7 September 2008."},{"key":"e_1_2_6_10_2","volume-title":"Ensuring the Effective Oversight of Genetic Tests Supplied Directly to the Public","author":"Human Genetics Commission","year":"2003"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2007.12.020"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1156604"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.299.11.1353"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp0708162"},{"key":"e_1_2_6_15_2","unstructured":"European Group on Ethics in Science and New Technologies.Statement by the European Group on Ethics in Science and New Technologies on advertising genetic tests via the Internet.2003. [cited 2009 Aug 10]. Available from URL:http:\/\/europa.eu\/rapid\/pressReleasesAction.do?reference=IP\/03\/273&format=HTML&aged=0&language=EN&guiLanguage=en"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000292086.98514.8b"},{"key":"e_1_2_6_17_2","first-page":"60","article-title":"ACMG statement on direct\u2010to\u2010consumer genetic testing","volume":"6","author":"American College of Medical Genetics Board of Directors","year":"2006","journal-title":"Genet Med"},{"key":"e_1_2_6_18_2","first-page":"83","article-title":"Direct\u2010to\u2010consumer online genetic testing and the four principles: an analysis of the ethical issues","volume":"22","author":"Wasson K","year":"2006","journal-title":"Ethics Med"},{"key":"e_1_2_6_19_2","unstructured":"Kennedy. Genetic Information Nondiscrimination Act 2008. 110th United States Congress. Bill number H.R. 493."},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1080\/15265160902928209"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2008.803"},{"key":"e_1_2_6_22_2","unstructured":"Australian Law Reform Commission and the Australian Health Ethics Committee of the NHMRC.Essentially Yours: The Protection of Human Genetic Information in Australia \u2013 Part C: Australian Law Reform Commission.2003. [cited 2009 Aug 10]. Available from URL:http:\/\/www.austlii.edu.au\/au\/other\/alrc\/publications\/reports\/96"},{"key":"e_1_2_6_23_2","unstructured":"Australian Government Response.2005. [cited 2009 Aug 10]. Available from URL:http:\/\/www.alrc.gov.au\/inquiries\/title\/alrc96\/response.htm"},{"key":"e_1_2_6_24_2","unstructured":"Therapeutic Goods Administration.The Regulation of Nutrigenetic Tests in Australia.2007. [cited 2009 Aug 10]. Available from URL:http:\/\/www.tga.gov.au\/devices\/ivd\u2010nutrigenetic.htm"},{"key":"e_1_2_6_25_2","unstructured":"Australian Law Reform Commission and the Australian Health Ethics Committee of the NHMRC.Direct\u2010to\u2010consumer Genetic Testing \u2013 Public Meeting Summary.2008. [cited 2009 Aug 10]. Available from URL:http:\/\/www.nhmrc.gov.au\/media\/events\/genetic_testing_summary.htm"},{"key":"e_1_2_6_26_2","unstructured":"Federal Trade Commission.At\u2010Home Genetic Tests: A Healthy Dose of Skepticism May Be the Best Prescription.2007. [cited 2009 Aug 10]. Available from URL:http:\/\/www.ftc.gov\/bcp\/edu\/pubs\/consumer\/health\/hea02.shtm"},{"key":"e_1_2_6_27_2","unstructured":"Genomics and Personalized Medicine Act S. 976. 110th Congress ed;2007."},{"key":"e_1_2_6_28_2","unstructured":"Laboratory Test Improvement Act. S.736. 110th Congress ed;2007."},{"key":"e_1_2_6_29_2","unstructured":"Organisation for Economic Co\u2010operation and Development.OECD Guidelines for Quality Assurance in Molecular Genetic Testing.2006. [cited 2009 Aug 10]. Available from URL:http:\/\/www.eurogentest.org\/aboutus\/db\/news\/117\/index.xhtml"},{"key":"e_1_2_6_30_2","unstructured":"Global Harmonization Task Force.Principles of In Vitro Diagnostic Medical Devices Classification and Principles of Conformity Assessment for In vitro Diagnostic Medical Devices.2007[cited 2009 Aug 10]. Available from URL:http:\/\/www.ghtf.org\/sg1\/sg1\u2010final.html"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/456034a"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0708-716"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1080\/15265160902874411"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.genom.9.081307.164319"}],"container-title":["Internal Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1445-5994.2010.02190.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1445-5994.2010.02190.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T09:39:02Z","timestamp":1698658742000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1445-5994.2010.02190.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["10.1111\/j.1445-5994.2010.02190.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1445-5994.2010.02190.x","archive":["Portico"],"relation":{},"ISSN":["1444-0903","1445-5994"],"issn-type":[{"value":"1444-0903","type":"print"},{"value":"1445-5994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"2010-03-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}